Sezaby Injection
Product Images NDC 62756-301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sezaby (NDC 62756-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Sezaby 1)

FDA Label Image

Image Description (Sezaby 2)

Image Description (Sezaby 2)
This is a pharmaceutical product containing Phenobarbital sodium, with each vial containing 100 mg. It requires reconstitution with 10 mL 0.9% Sodium Chloride Injection, USP, resulting in a final concentration of 100 mg/10 mL (10 mg/ml) of Phenobarbital sodium. It is for slow intravenous use only after reconstitution, and is a single-dose vial. The recommended dosage and storage information can be found in the package insert. It is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Medicare Ltd. in India. The lot and expiration date are also provided.*
FDA Label Image

Image Description (Sezaby 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.